Literature DB >> 20225271

Rottlerin inhibits migration of follicular thyroid carcinoma cells by PKCdelta-independent destabilization of the focal adhesion complex.

Chien-Jung Lin1, Chieh-Yu Lin, Ying Chen, Shih-Horng Huang, Seu-Mei Wang.   

Abstract

This study examined the effect of rottlerin on the focal adhesion-mediated cell migration of CGTH W-2 human follicular thyroid carcinoma cells. Rottlerin (10 microM) resulted in decreased adhesion of CGTH W-2 cells to matrix substance, which was correlated with metastatic potential. Rottlerin treatment also resulted in a marked reduction in the migration of CGTH W-2 cells. Protein levels of integrin beta1, FAK, and paxillin were decreased by rottlerin. Consistent with this, immunostaining of FAK, vinculin, and paxillin revealed disassembly of the focal adhesions. Disruption of actin stress fibers was noted, which was compatible with reduced expression levels and activities of Rac-1 and Rho. The effect of rottlerin on cell migration was not attributable to inhibition of PKCdelta activity since siRNA knockdown of PKCdelta did not recapitulate the effects of rottlerin on cell adhesion and migration. Furthermore, activation of PKCdelta by phorbol esters failed to restore the rottlerin-inhibited migratory ability. The mitochondrial uncoupler, carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone, was able to mimic several rottlerin's effects. In summary, we demonstrated that rottlerin inhibits the migration of CGTH W-2 cells by disassembly of focal adhesion complexes in a PKCdelta-independent manner, and might play as a mitochondrial uncoupler role in these events. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20225271     DOI: 10.1002/jcb.22555

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  Rottlerin inhibits cell growth and invasion via down-regulation of EZH2 in prostate cancer.

Authors:  Nana Zheng; Lixia Wang; Yingying Hou; Xiuxia Zhou; Youhua He; Zhiwei Wang
Journal:  Cell Cycle       Date:  2018-11-15       Impact factor: 4.534

2.  Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.

Authors:  Wenyan Lu; Cuihong Lin; Yonghe Li
Journal:  Cell Signal       Date:  2014-03-06       Impact factor: 4.315

3.  uPAR and cathepsin B knockdown inhibits radiation-induced PKC integrated integrin signaling to the cytoskeleton of glioma-initiating cells.

Authors:  Kiranmai Alapati; Sreelatha Gopinath; Rama Rao Malla; Venkata Ramesh Dasari; Jasti S Rao
Journal:  Int J Oncol       Date:  2012-05-24       Impact factor: 5.650

Review 4.  Rottlerin and cancer: novel evidence and mechanisms.

Authors:  E Maioli; C Torricelli; G Valacchi
Journal:  ScientificWorldJournal       Date:  2012-01-04

5.  Rottlerin exerts its anti-tumor activity through inhibition of Skp2 in breast cancer cells.

Authors:  Xuyuan Yin; Yu Zhang; Jingna Su; Yingying Hou; Lixia Wang; Xiantao Ye; Zhe Zhao; Xiuxia Zhou; Yali Li; Zhiwei Wang
Journal:  Oncotarget       Date:  2016-10-11

6.  Rottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cells.

Authors:  Lixia Wang; Yingying Hou; Xuyuan Yin; Jingna Su; Zhe Zhao; Xiantao Ye; Xiuxia Zhou; Li Zhou; Zhiwei Wang
Journal:  Oncotarget       Date:  2016-10-25

7.  Rottlerin promotes autophagy and apoptosis in gastric cancer cell lines.

Authors:  Jun Song; Yan Zhou; Yu Gong; Hanyang Liu; Liming Tang
Journal:  Mol Med Rep       Date:  2018-07-16       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.